Adipogenesis is under surveillance of Hsp90 and the high molecular weight immunophilin FKBP51

Adipocyte

Volumn 4, Issue 4, 2015, Pages 239-247

  Toneatto, Judith ^a   Charó, Nancy L ^a   Galigniana, Natalia M ^a   Piwien Pilipuk, Graciela ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Adipogenesis; FKBP51; Hsp90; Nuclear lamina; PPAR

Indexed keywords

CELL NUCLEUS RECEPTOR; FK 506 BINDING PROTEIN; GELDANAMYCIN; GLUCOSE REGULATED PROTEIN 94; HEAT SHOCK PROTEIN 90; HIGH MOLECULAR WEIGHT IMMUNOPHILIN; IMMUNOPHILIN; MITOGEN ACTIVATED PROTEIN KINASE 14; PEPTIDYLPROLYL ISOMERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL TRANSFORMATION; GENE TARGETING; GENOME ANALYSIS; IMMUNOPRECIPITATION; LIPODYSTROPHY; MITOCHONDRION; NONHUMAN; NUCLEAR LAMINA; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FOLDING; REVIEW; SIGNAL TRANSDUCTION; TETRATRICOPEPTIDE REPEAT;

EID: 84978740315     PISSN: 21623945     EISSN: 2162397X     Source Type: Journal    
DOI: 10.1080/21623945.2015.1049401     Document Type: Review

References (141)

1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89:2548-56. PMID:15181022. http://dx.doi.org/10.1210/jc.2004-0395
2. Schwartz MW, Porte D, Jr. Diabetes, obesity, and the brain. Science 2005; 307:375-9. PMID:15662002. http://dx.doi.org/10.1126/science.1104344
3. Olefsky JM. Fat talks, liver and muscle listen. Cell 2008; 134:914-6. PMID:18805083. http://dx.doi.org/10.1016/j.cell.2008.09.001
4. Das M, Gabriely I, Barzilai N. Caloric restriction, body fat and ageing in experimental models. Obes Rev 2004; 5:13-9. PMID:14969503. http://dx.doi.org/10.1111/j.1467-789X.2004.00115.x
5. Cawthorn WP, Scheller EL, Learman BS, Parlee SD, Simon BR, Mori H, Ning X, Bree AJ, Schell B, Broome DT, et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab 2014; 20:368-75. PMID:24998914. http://dx.doi.org/10.1016/j.cmet.2014.06.003
6. Weyer C, Wolford JK, Hanson RL, Foley JE, Tataranni PA, Bogardus C, Pratley RE. Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21-q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol Genet Metab 2001; 72:231-8. PMID:11243729. http://dx.doi.org/10.1006/mgme.2001.3147
7. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-808. PMID:14679176; http://dx.doi.org/10.1172/JCI200319246
8. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, Mukundan L, Brombacher F, Locksley RM, Chawla A. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogene-sis. Nature 2011; 480:104-8. PMID:22101429. http://dx.doi.org/10.1038/nature10653
9. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001; 409:729-33. PMID:11217863. http://dx.doi.org/10.1038/35055575
10. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294:2166-70. PMID:11739957. http://dx.doi.org/10.1126/science.1066285
11. Lee MJ, Pramyothin P, Karastergiou K, Fried SK. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity. Biochim Biophys Acta 2014; 1842:473-81. http://dx.doi.org/10.1016/j.bbadis.2013.05.029
12. Marzolla V, Armani A, Zennaro MC, Cinti F, Mammi C, Fabbri A, Rosano GM, Caprio M. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol Cell Endocrinol 2012; 350:281-8. PMID:21945603. http://dx.doi.org/10.1016/j.mce.2011.09.011
13. Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol 2014; 220:T47-59. PMID:24403378. http://dx.doi.org/10.1530/JOE-13-0339
14. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007; 56:16-23. PMID:17192460; http://dx.doi.org/10.2337/db06-1076
15. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macro-phages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008; 57:3239-46. PMID:18829989. http://dx.doi.org/10.2337/db08-0872
16. Lumeng CN, Saltiel AR Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121:2111-7. PMID:21633179. http://dx.doi.org/10.1172/JCI57132
17. Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, Wang ZV, Scherer PE. Adipo-cyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 2014; 20:103-18. PMID:24930973. http://dx.doi.org/10.1016/j.cmet.2014.05.005
18. Garg A, Agarwal AK. Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta 2009; 1791:507-13. PMID:19162222. http://dx.doi.org/10.1016/j.bbalip.2008.12.014
19. Krahmer N, Farese RV, Jr., Walther TC. Balancing the fat: lipid droplets and human disease. EMBO Mol Med 2013; 5:905-15. PMID:23740690. http://dx.doi.org/10.1002/emmm.201100671
20. Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, Pfeiffer EF. Promoting effect of glucocorticoids on the differentiation of human adi-pocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989; 84:1663-70. PMID:2681273. http://dx.doi.org/10.1172/JCI114345
21. Gaillard D, Wabitsch M, Pipy B, Negrel R. Control of terminal differentiation of adipose precursor cells by glucocorticoids. J Lipid Res 1991; 32:569-79. PMID:1649886
22. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998; 78:783-809. PMID:9674695
23. Rondinone CM, Rodbard D, Baker ME. Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology 1993; 132:2421-6. PMID:8504747
24. Caprio M, Feve B, Claes A, Viengchareun S, Lombes M, Zennaro MC. Pivotal role of the mineralocorti-coid receptor in corticosteroid-induced adipogenesis. Faseb J 2007; 21:2185-94. PMID:17384139; http://dx.doi.org/10.1096/fj.06-7970com
25. Pedersen SB, Jonler M, Richelsen B. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab 1994; 78:13549. PMID:8200937
26. Peckett AJ, Wright DC, Riddell MC. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism 2011; 60:1500-10. PMID:21864867. http://dx.doi.org/10.1016/j.metabol.2011.06.012
27. Patsouris D, Neels JG, Fan W, Li PP, Nguyen MT, Olefsky JM. Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage che-motaxis and recruitment. J Biol Chem 2009; 284:31223-35. PMID:19740750. http://dx.doi.org/10.1074/jbc.M109.041665
28. Pratt WB, Galigniana MD, Morishima Y, Murphy PJ. Role of molecular chaperones in steroid receptor action. Essays Biochem 2004; 40:41-58. PMID:15242338
29. Smith DF, Toft DO. Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions. Mol Endocrinol 2008; 22:222940. PMID:18451092. http://dx.doi.org/10.1210/me.2008-0089
30. McKeen HD, McAlpine K, Valentine A, Quinn DJ, McClelland K, Byrne C, O'Rourke M, Young S, Scott CJ, McCarthy HO, et al. A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling. Endocrinology 2008; 149:5724-34. PMID:18669603. http://dx.doi.org/10.1210/en.2008-0168
31. Welch WJ, Feramisco JR. Purification of the major mammalian heat shock proteins. J Biol Chem 1982; 257:14949-59. PMID:7174676
32. Lai BT, Chin NW, Stanek AE, Keh W, Lanks KW. Quantitation and intracellular localization of the 85K heat shock protein by using monoclonal and poly-clonal antibodies. Mol Cell Biol 1984; 4:2802-10. PMID:6396506
33. Nollen EA, Morimoto RI. Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J Cell Sci 2002; 115:2809-16. PMID:12082142
34. Sreedhar AS, Kalmar E, Csermely P, Shen YF. Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett 2004; 562:11-5. PMID:15069952. http://dx.doi.org/10.1016/S0014-5793(04)00229-7
35. Johnson JL. Evolution and function ofdiverse Hsp90 homologs and cochaperone proteins. Biochim Bio-phys Acta 2012; 1823:607-13. PMID:22008467. http://dx.doi.org/10.1016/j.bbamcr.2011.09.020
36. Chen B, Piel WH, Gui L, Bruford E, Monteiro A. The HSP90 family of genes in the human genome: insights into their divergence and evolution. Genomics 2005; 86:627-37. PMID:16269234. http://dx.doi.org/10.1016/j.ygeno.2005.08.012
37. Shen Y, Liu J, Wang X, Cheng X, Wang Y, Wu N. Essential role of the first intron in the transcription of hsp90beta gene. FEBS Lett 1997; 413:92-8. PMID:9287123. http://dx.doi.org/10.1016/S0014-5793(97)00883-1
38. Chen XS, Zhang Y, Wang JS, Li XY, Cheng XK, Zhang Y, Wu NH, Shen YF. Diverse effects of Stat1 on the regulation of hsp90alpha gene under heat shock. J Cell Biochem 2007; 102:1059-66. PMID:17427945. http://dx.doi.org/10.1002/jcb.21342
39. Toneatto J, Guber S, Charo NL, Susperreguy S, Schwartz J, Galigniana MD, Piwien-Pilipuk G. Dynamic mitochondrial-nuclear redistribution of the immunophilin FKBP51 is regulated by the PKA signaling pathway to control gene expression during adi-pocyte differentiation. J Cell Sci 2013; 126:5357-68. PMID:24101724. http://dx.doi.org/10.1242/jcs.125799
40. Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 2010; 11:515-28. PMID:20531426. http://dx.doi.org/10.1038/nrm2918
41. Taipale M, Krykbaeva I, Koeva M, Kayatekin C, Westover KD, Karras GI, Lindquist S. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell 2012; 150:987-1001. PMID:22939624. http://dx.doi.org/10.1016/j.cell.2012.06.047
42. Erlejman AG, Lagadari M, Toneatto J, Piwien-Pili-puk G, Galigniana MD. Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression. Biochim Biophys Acta 2014; 1839:71-87. PMID:24389346. http://dx.doi.org/10.1016/j.bbagrm.2013.12.006
43. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008; 77:289-312. PMID:18518822. http://dx.doi.org/10.1146/annurev.biochem.77.061307.091829
44. Lefterova MI, Haakonsson AK, Lazar MA, Mandrup S. PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol Metab 2014; 25:293302. PMID:24793638. http://dx.doi.org/10.1016/j. tem.2014.04.001
45. Sumanasekera WK, Tien ES, Davis JW, 2nd, Turpey R, Perdew GH, Vanden Heuvel JP. Heat shock protein-90 (Hsp90) acts as a repressor ofperoxisome proliferator-acti-vated receptor-a (PPARalpha) and PPARbeta activity. Biochemistry 2003; 42:10726-35. PMID:12962497. http://dx.doi.org/10.1021/bi0347353
46. Sumanasekera WK, Tien ES, Turpey R, Vanden Heuvel JP, Perdew GH. Evidence that peroxisome proliferator-activated receptor a is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2. J Biol Chem 2003; 278:4467-73. PMID:12482853. http://dx.doi.org/10.1074/jbc.M211261200
47. Nguyen MT, Csermely P, Soti C. Hsp90 chaperones PPARgamma and regulates differentiation and survival of 3T3-L1 adipocytes. Cell Death Differ 2013; 20:1654-63. PMID:24096869. http://dx.doi.org/10.1038/cdd.2013.129
48. Desarzens S, Liao WH, Mammi C, Caprio M, Faresse N. Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation. PLoS One 2014; 9: e94127. PMID:24705830. http://dx.doi.org/10.1371/journal.pone.0094127
49. da Silva VC, Ramos CH. The network interaction of the human cytosolic 90 kDa heat shock protein Hsp90: A target for cancer therapeutics. J Proteomics 2012; 75:2790-802. PMID:22236519. http://dx.doi.org/10.1016/j.jprot.2011.12.028
50. Sawarkar R, Sievers C, Paro R. Hsp90 globally targets paused RNA polymerase to regulate gene expression in response to environmental stimuli. Cell 2012; 149:807-18. PMID:22579285. http://dx.doi.org/10.1016/j.cell.2012.02.061
51. Sivils JC, Storer CL, Galigniana MD, CoxMB. Regulation ofsteroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52). Curr Opin Pharmacol 2011; 11:314-9. PMID:21511531; http://dx.doi.org/10.1016/j.coph.2011.03.010
52. Pirkl F, Buchner J. Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40. J Mol Biol 2001; 308:795-806. PMID:11350175. http://dx.doi.org/10.1006/jmbi.2001.4595
53. Riggs DL, Roberts PJ, Chirillo SC, Cheung-Flynn J, Prapapanich V, Ratajczak T, Gaber R, Picard D, Smith DF. The Hsp90-binding peptidylprolyl isom-erase FKBP52 potentiates glucocorticoid signaling in vivo. Embo J 2003; 22:1158-67. PMID:12606580. http://dx.doi.org/10.1093/emboj/cdg108
54. Sinars CR, Cheung-Flynn J, Rimerman RA, Scam-mell JG, Smith DF, Clardy J. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc Natl Acad Sci U S A 2003; 100:868-73. PMID:12538866. http://dx.doi.org/10.1073/pnas.0231020100
55. Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 2005; 280:4609-16. PMID:15591061. http://dx.doi.org/10.1074/jbc. M407498200
56. Davies TH, Ning YM, Sanchez ER. A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 2002; 277:4597-600. PMID:11751894. http://dx.doi.org/10.1074/jbc.C100531200
57. Gallo LI, Ghini AA, Piwien Pilipuk G, Galigniana MD. Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorti-coid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity. Biochemistry 2007; 46:14044-57. PMID:18001136. http://dx.doi.org/10.1021/bi701372c
58. Erlejman AG, De Leo SA, Mazaira GI, Molinari AM, Camisay MF, Fontana V, Cox MB, Piwien-Pilipuk G, Galigniana MD. NF-kappaB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyL-prolyl isomerase activity. J Biol Chem 2014; 289:26263-76. PMID:25104352. http://dx.doi.org/10.1074/jbc.M114.582882
59. Yeh WC, Li TK, Bierer BE, McKnight SL. Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipo-cyte differentiation. Proc Natl Acad Sci U S A 1995; 92:11081-5. PMID:7479941. http://dx.doi.org/10.1073/pnas.92.24.11081
60. Stechschulte LA, Hinds TD, Jr., Ghanem SS, Shou W, Najjar SM, Sanchez ER. FKBP51 reciprocally regulates GRalpha and PPARgamma activation via the Akt-p38 pathway. Mol Endocrinol 2014; 28:125464. PMID:24933248. http://dx.doi.org/10.1210/me.2014-1023
61. Warrier M, Hinds TD, Jr., Ledford KJ, Cash HA, Patel PR, Bowman TA, Stechschulte LA, Yong W, Shou W, Najjar SM, et al. Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice. Endocrinology 2010; 151:3225-36. PMID:20427484; http://dx.doi.org/10.1210/en.2009-1158
62. Hubler TR, Denny WB, Valentine DL, Cheung-Flynn J, Smith DF, Scammell JG. The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology 2003; 144:2380-7. PMID:12746298. http://dx.doi.org/10.1210/en.2003-0092
63. Hubler TR, Scammell JG. Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 2004; 9:243-52. PMID:15544162. http://dx.doi.org/10.1379/CSC-32R.1
64. Scammell JG, Hubler TR, Denny WB, Valentine DL. Organization of the human FK506-binding immuno-philin FKBP52 protein gene (FKBP4). Genomics 2003; 81:640-3. PMID:12782134. http://dx.doi.org/10.1016/S0888-7543(03)00090-9
65. Baughman G, Wiederrecht GJ, Chang F, Martin MM, Bourgeois S. Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition. Biochem Biophys Res Commun 1997; 232:437-43. PMID:9125197. http://dx.doi.org/10.1006/bbrc.1997.6307
66. Reynolds PD, Roveda KP, Tucker JA, Moore CM, Valentine DL, Scammell JG. Glucocorticoid-resistant B-lymphoblast cell line derived from the Bolivian squirrel monkey (Saimiri boliviensis boliviensis). Lab Anim Sci 1998; 48:364-70. PMID:10090044
67. Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glu-cocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 2003; 88:277-84. PMID:12519866. http://dx.doi.org/10.1210/jc.2002-020354
68. Kester HA, van der Leede BM, van der Saag PT, van der Burg B. Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J Biol Chem 1997; 272:16637-43. PMID:9195978. http://dx.doi.org/10.1074/jbc.272.26.16637
69. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 2002; 277:5209-18. PMID:11717311. http://dx.doi.org/10.1074/jbc. M110090200
70. Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, et al. Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res 2000; 60:6134-41. PMID:11085537
71. Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, Bittner M, Pretlow T, Elkahloun AG, Trepel JB, Kallioniemi OP. Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling. Oncogene 2001; 20:6718-23. PMID:11709706. http://dx.doi.org/10.1038/sj. onc.1204889
72. Kumar P, Mark PJ, Ward BK, Minchin RF, Ratajczak T. Estradiol-regulated expression of the immunophi-lins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem Biophys Res Commun 2001; 284:219-25. PMID:11374893. http://dx.doi.org/10.1006/bbrc.2001.4952
73. Mark PJ, Ward BK, Kumar P, Lahooti H, Minchin RF, Ratajczak T. Human cyclophilin 40 is a heat shock protein that exhibits altered intracellular localization following heat shock. Cell Stress Chaperones 2001; 6:59-70. PMID:11525244. http://dx.doi.org/10.1379/1466-1268(2001)006%3c0059: HCIAHS%3e2.0.CO;2
74. Gallo LI, Lagadari M, Piwien-Pilipuk G, Galigniana MD. The 90-kDa Heat-shock Protein (Hsp90)-binding Immunophilin FKBP51 Is a Mitochondrial Protein That Translocates to the Nucleus to Protect Cells against Oxidative Stress. J Biol Chem 2011; 286:30152-60. PMID:21730050. http://dx.doi.org/10.1074/jbc.M111.256610
75. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006; 7:885-96. PMID:17139329. http://dx.doi.org/10.1038/nrm2066
76. Reusch JE, Colton LA, Klemm DJ. CREB activation induces adipogenesis in 3T3-L1 cells. Mol Cell Biol 2000; 20:1008-20. PMID:10629058. http://dx.doi.org/10.1128/MCB.20.3.1008-1020.2000
77. Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K, D0skeland SO, Kristiansen K. Cyclic AMP (cAMP)-mediated stimulation of adipo-cyte differentiation requires the synergistic action of Epac-and cAMP-dependent protein kinase-depen-dent processes. Mol Cell Biol 2008; 28:3804-16. PMID:18391018. http://dx.doi.org/10.1128/MCB.00709-07
78. Martini CN, Plaza MV, Vila Mdel C. PKA-depen-dent and independent cAMP signaling in 3T3-L1 fibroblasts differentiation. Mol Cell Endocrinol 2009; 298:42-7. PMID:19010385. http://dx.doi.org/10.1016/j.mce.2008.10.023
79. Xiao H, Leblanc SE, Wu Q, Konda S, Salma N, Marfella CG, Ohkawa Y, Imbalzano AN. Chromatin accessibility and transcription factor binding at the PPARgamma2 promoter during adipogenesis is protein kinase A-dependent. J Cell Physiol 2011; 226:8693. PMID:20625991. http://dx.doi.org/10.1002/jcp.22308
80. Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, Denissov S, B0rgesen M, Francoijs KJ, Mandrup S, et al. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 2008; 22:295367. PMID:18981474. http://dx.doi.org/10.1101/gad.501108
81. Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A, Feng D, Zhuo D, Stoeckert CJ Jr, Liu XS, et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008; 22:2941-52. PMID:18981473. http://dx.doi.org/10.1101/gad.1709008
82. Steger DJ, Grant GR, Schupp M, Tomaru T, Lefter-ova MI, Schug J, Manduchi E, Stoeckert CJ Jr, Lazar MA. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev 2010; 24:1035-44. PMID:20478996. http://dx.doi.org/10.1101/gad.1907110
83. Siersbaek R, Nielsen R, John S, Sung MH, Baek S, Loft A, Hager GL, Mandrup S. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. Embo J 2011; 30:1459-72. PMID:21427703. http://dx.doi.org/10.1038/emboj.2011.65
84. Susperreguy S, Prendes LP, Desbats MA, Charo NL, Brown K, MacDougald OA, Kerppola T, Schwartz J, Piwien-Pilipuk G. Visualization by BiFC of different C/EBPbeta dimers and their interaction with HP1al-pha reveals a differential subnuclear distribution of complexes in living cells. Exp Cell Res 2011; 317:706-23. PMID:21122806. http://dx.doi.org/10.1016/j.yexcr.2010.11.008
85. Berg AH, Lin Y, Lisanti MP, Scherer PE. Adipocyte differentiation induces dynamic changes in NF-kap-paB expression and activity. Am J Physiol Endocrinol Metab 2004; 287:E1178-88. PMID:15251865. http://dx.doi.org/10.1152/ajpendo.00002.2004
86. Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phos-phorylation of PPARgamma. Science 1996; 274:2100-3. PMID:8953045. http://dx.doi.org/10.1126/science.274.5295.2100
87. Adams M, Reginato MJ, Shao D, Lazar MA, Chatter-jee VK. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 1997; 272:5128-32. PMID:9030579. http://dx.doi.org/10.1074/jbc.272.8.5128
88. Camp HS, Tafuri SR. Regulation of peroxisome pro-liferator-activated receptor gamma activity by mito-gen-activated protein kinase. J Biol Chem 1997; 272:10811-6. PMID:9099735. http://dx.doi.org/10.1074/jbc.272.16.10811
89. Aouadi M, Laurent K, Prot M, Le Marchand-Brustel Y, Binetruy B, Bost F. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 2006; 55:281-9. PMID:16443758; http://dx.doi.org/10.2337/diabetes.55.02.06.db05-0963
90. Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocor-ticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation ofthe human glucocorticoid receptor at serine 211. Mol Endocrinol 2005; 19:1569-83. PMID:15817653. http://dx.doi.org/10.1210/me.2004-0528
91. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lin-gle W, Petersen G, Lou Z, Wang L. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 2009; 16:259-66. PMID:19732725. http://dx.doi.org/10.1016/j. ccr.2009.07.016
92. Engelman JA, Lisanti MP, Scherer PE. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 1998; 273:3211120. PMID:9822687. http://dx.doi.org/10.1074/jbc.273.48.32111
93. Engelman JA, Berg AH, Lewis RY, Lin A, Lisanti MP, Scherer PE. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis. J Biol Chem 1999; 274:35630-8. PMID:10585441. http://dx.doi.org/10.1074/jbc.274.50.35630
94. Hata K, Nishimura R, Ikeda F, Yamashita K, Matsu-bara T, Nokubi T, Yoneda T. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 2003; 14:545-55. PMID:12589053; http://dx.doi.org/10.1091/mbc.E02-06-0356
95. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003; 17:1352-65. PMID:12782654. http://dx.doi.org/10.1101/gad.1089403
96. Magun R, Burgering BM, Coffer PJ, Pardasani D, Lin Y, Chabot J, Sorisky A. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 1996; 137:3590-3. PMID:8754791
97. Nakae J, Kitamura T, Kitamura Y, Biggs WH, Arden KC, Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 2003; 4:119-29. PMID:12530968. http://dx.doi.org/10.1016/S1534-5807(02)00401-X
98. Wolfrum C, Shih DQ, Kuwajima S, Norris AW, Kahn CR, Stoffel M. Role of Foxa-2 in adipocyte metabolism and differentiation. J Clin Invest 2003; 112:345-56. PMID:12865419. http://dx.doi.org/10.1172/JCI18698
99. Menghini R, Marchetti V, Cardellini M, Hribal ML, Mauriello A, Lauro D, Sbraccia P, Lauro R, Federici M. Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to atherosclerosis. Circulation 2005; 111:1946-53. PMID:15837948. http://dx.doi.org/10.1161/01.CIR.0000161814.02942.B2
100. Ho CY, Lammerding J. Lamins at a glance. J Cell Sci 2012; 125:2087-93. PMID:22669459. http://dx.doi.org/10.1242/jcs.087288
101. Nickerson J. Experimental observations of a nuclear matrix. J Cell Sci 2001; 114:463-74. PMID:11171316
102. Cremer T, Zakhartchenko V. Nuclear architecture in developmental biology and cell specialisation. Reprod Fertil Dev 2011; 23:94-106. PMID:21366985. http://dx.doi.org/10.1071/RD10249
103. Chung I, Osterwald S, Deeg KI, Rippe K. PML body meets telomere: the beginning of an ALTernate ending? Nucleus 2012; 3:263-75. PMID:22572954. http://dx.doi.org/10.4161/nucl.20326
104. Koehler D, Zakhartchenko V, Froenicke L, Stone G, Stanyon R, Wolf E, Cremer T, Brero A. Changes of higher order chromatin arrangements during major genome activation in bovine preimplantation embryos. Exp Cell Res 2009; 315:2053-63. PMID:19254712. http://dx.doi.org/10.1016/j.yexcr.2009.02.016
105. Solovei I, Kreysing M, Lanctot C, Kosem S, Peichl L, Cremer T, Guck J, Joffe B. Nuclear architecture of rod photoreceptor cells adapts to vision in mammalian evolution. Cell 2009; 137:356-68. PMID:19379699. http://dx.doi.org/10.1016/j.cell.2009.01.052
106. Kuroda M, Tanabe H, Yoshida K, Oikawa K, Saito A, Kiyuna T, Mizusawa H, Mukai K. Alteration of chromosome positioning during adipocyte differentiation. J Cell Sci 2004; 117:5897-903. PMID:15537832. http://dx.doi.org/10.1242/jcs.01508
107. Szczerbal I, Foster HA, Bridger JM. The spatial repositioning of adipogenesis genes is correlated with their expression status in a porcine mesenchymal stem cell adipogenesis model system. Chromosoma 2009; 118:647-63. PMID:19585140. http://dx.doi.org/10.1007/s00412-009-0225-5
108. Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fisher AG. Association of transcrip-tionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 1997; 91:845-54. PMID:9413993. http://dx.doi.org/10.1016/S0092-8674(00)80472-9
109. Brown KE, Baxter J, Graf D, Merkenschlager M, Fisher AG. Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. Mol Cell 1999; 3:207-17. PMID:10078203; http://dx.doi.org/10.1016/S1097-2765(00)80311-1
110. Volpi EV, Chevret E, Jones T, Vatcheva R, Williamson J, Beck S, Campbell RD, Goldsworthy M, Powis SH, Ragoussis J, et al. Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci 2000; 113 (Pt 9):1565-76. PMID:10751148
111. Kosak ST, Skok JA, Medina KL, Riblet R, Le Beau MM, Fisher AG, Singh H. Subnuclear compartmen-talization of immunoglobulin loci during lymphocyte development. Science 2002; 296:158-62. PMID:11935030. http://dx.doi.org/10.1126/science.1068768
112. Taddei A, Van Houwe G, Hediger F, Kalck V, Cubizolles F, Schober H, Gasser SM. Nuclear pore association confers optimal expression levels for an inducible yeast gene. Nature 2006; 441:774-8. PMID:16760983. http://dx.doi.org/10.1038/nature04845
113. Sexton T, Schober H, Fraser P, Gasser SM. Gene regulation through nuclear organization. Nat Struct Mol Biol 2007; 14:1049-55. PMID:17984967. http://dx.doi.org/10.1038/nsmb1324
114. Meister P, Towbin BD, Pike BL, Ponti A, Gasser SM. The spatial dynamics of tissue-specific promoters during C. elegans development. Genes Dev 2010; 24:766-82. PMID:20395364. http://dx.doi.org/10.1101/gad.559610
115. Bickmore WA, van Steensel B. Genome architecture: domain organization of interphase chromosomes. Cell 2013; 152:1270-84. PMID:23498936. http://dx.doi.org/10.1016/j.cell.2013.02.001
116. Fawcett DW. On the occurrence of a fibrous lamina on the inner aspect of the nuclear envelope in certain cells of vertebrates. Am J Anat 1966; 119:129-45. PMID:6007824. http://dx.doi.org/10.1002/aja.1001190108
117. Patrizi G, Poger M. The ultrastructure of the nuclear periphery. The zonula nucleum limitans. J Ultrastruct Res 1967; 17:127-36. PMID:6017352. http://dx.doi.org/10.1016/S0022-5320(67)80025-X
118. Wilson KL, Berk JM. The nuclear envelope at a glance. J Cell Sci 2010; 123:1973-8. PMID:20519579. http://dx.doi.org/10.1242/jcs.019042
119. Hirata A, Maeda N, Nakatsuji H, Hiuge-Shimizu A, Okada T, Funahashi T, Shimomura I. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction. Biochem Biophys Res Commun 2012; 419:182-7. PMID:22326264. http://dx.doi.org/10.1016/j. bbrc.2012.01.139
120. McKeon FD, Kirschner MW, Caput D. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 1986; 319:463-8. PMID:3453101. http://dx.doi.org/10.1038/319463a0
121. Shimi T, Pfleghaar K, Kojima S, Pack CG, Solovei I, Goldman AE, Adam SA, Shumaker DK, Kinjo M, Cremer T, et al. The A-and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. Genes Dev 2008; 22:3409-21. PMID:19141474. http://dx.doi.org/10.1101/gad.1735208
122. Shimi T, Butin-Israeli V, Goldman RD. The functions of the nuclear envelope in mediating the molecular crosstalk between the nucleus and the cytoplasm. Curr Opin Cell Biol 2012; 24:71-8. PMID:22192274. http://dx.doi.org/10.1016/j.ceb.2011.11.007
123. Worman HJ, Bonne G. "Laminopathies:" a wide spectrum of human diseases. Exp Cell Res 2007; 313:2121-33. PMID:17467691. http://dx.doi.org/10.1016/j.yexcr.2007.03.028
124. Shimi T, Butin-Israeli V, Adam SA, Goldman RD. Nuclear lamins in cell regulation and disease. Cold Spring Harb Symp Quant Biol 2010; 75:525-31. PMID:21467145. http://dx.doi.org/10.1101/sqb.2010.75.045
125. de Las Heras JI, Meinke P, Batrakou DG, Srsen V, Zuleger N, Kerr AR, Schirmer EC. Tissue specificity in the nuclear envelope supports its functional complexity. Nucleus 2014; 4:460-77. PMID:24213376. http://dx.doi.org/10.4161/nucl.26872
126. Hegele RA, Joy TR, Al-Attar SA, Rutt BK. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res 2007; 48:1433-44. PMID:17374881. http://dx.doi.org/10.1194/jlr.R700004-JLR200
127. Garg A. Acquired and inherited lipodystrophies. N Engl J Med 2004; 350:1220-34. PMID:15028826. http://dx.doi.org/10.1056/NEJMra025261
128. Tilgner K, Wojciechowicz K, Jahoda C, Hutchison C, Markiewicz E. Dynamic complexes of A-type lamins and emerin influence adipogenic capacity of the cell via nucleocytoplasmic distribution of fl-catenin. J Cell Sci 2009; 122:401-13. PMID:19126678. http://dx.doi.org/10.1242/jcs.026179
129. Markiewicz E, Tilgner K, Barker N, van de Wetering M, Clevers H, Dorobek M, Hausmanowa-Petrusewicz I, Ramaekers FC, Broers JL, Blankesteijn WM, et al. The inner nuclear membrane protein emerin regulates fl-catenin activity by restricting its accumulation in the nucleus. Embo J 2006; 25:3275-85. PMID:16858403. http://dx.doi.org/10.1038/sj.emboj.7601230
130. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA. Inhibition ofadi-pogenesis by Wnt signaling. Science 2000; 289:950-3. PMID:10937998. http://dx.doi.org/10.1126/science.289.5481.950
131. Verstraeten VL, Renes J, Ramaekers FC, Kamps M, Kuijpers HJ, Verheyen F, Wabitsch M, Steijlen PM, van Steensel MA, Broers JL. Reorganization of the nuclear lamina and cytoskeleton in adipogenesis. Histochem Cell Biol 2011; 135:251-61. PMID:21350821. http://dx.doi.org/10.1007/s00418-011-0792-4
132. D'Angelo MA, Hetzer MW. The role of the nuclear envelope in cellular organization. Cell Mol Life Sci 2006; 63:316-32. PMID:16389459. http://dx.doi.org/10.1007/s00018-005-5361-3
133. Stuurman N. Identification of a conserved phosphory-lation site modulating nuclear lamin polymerization. FEBS Lett 1997; 401:171-4. PMID:9013881; http://dx.doi.org/10.1016/S0014-5793(96)01464-0
134. Gonzalez JM, Navarro-Puche A, Casar B, Crespo P, Andres V. Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J Cell Biol 2008; 183:653-66. PMID:19015316. http://dx.doi.org/10.1083/jcb.200805049
135. O'Leary JC, 3rd, Dharia S, Blair LJ, Brady S, Johnson AG, Peters M, Cheung-Flynn J, Cox MB, de Eraus-quin G, Weeber EJ, et al. A new anti-depressive strategy for the elderly: ablation ofFKBP5/FKBP51. PLoS One 2011; 6:e24840. PMID:21935478. http://dx.doi.org/10.1371/journal.pone.0024840
136. Touma C, Gassen NC, Herrmann L, Cheung-Flynn J, Bull DR, Ionescu IA, Heinzmann JM, Knapman A, Siebertz A, Depping AM, et al. FK506 binding protein 5 shapes stress responsiveness: modulation ofneu-roendocrine reactivity and coping behavior. Biol Psychiatry 2011; 70:928-36. PMID:21907973. http://dx.doi.org/10.1016/j.biopsych.2011.07.023
137. Hartmann J, Wagner KV, Liebl C, Scharf SH, Wang XD, Wolf M, Hausch F, Rein T, Schmidt U, Touma C, et al. The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharma-cology 2012; 62:332-9. PMID:21839098. http://dx.doi.org/10.1016/j.neuropharm.2011.07.041
138. Balsevich G, Uribe A, Wagner KV, Hartmann J, San-tarelli S, Labermaier C, Schmidt MV. Interplay between diet-induced obesity and chronic stress in mice: potential role of FKBP51. J Endocrinol 2014; 222:15-26. PMID:24781256. http://dx.doi.org/10.1530/JOE-14-0129
139. Tamashiro KL. Metabolic syndrome: links to social stress and socioeconomic status. Ann N Y Acad Sci 2011; 1231:46-55. PMID:21884160. http://dx.doi.org/10.1111/j.1749-6632.2011.06134.x
140. Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez-Quian C, Smith DF. Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol Endocrinol 2005; 19:1654-66. PMID:15831525. http://dx.doi.org/10.1210/me.2005-0071
141. Yong W, Yang Z, Periyasamy S, Chen H, Yucel S, Li W, Lin LY, Wolf IM, Cohn MJ, Baskin LS, et al. Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology. J Biol Chem 2007; 282:5026-36. PMID:17142810. http://dx.doi.org/10.1074/jbc. M609360200